Crystal structure of human NA-45 Fab in complex with neuraminidase Y169aH mutant from A/Shanghai/2/2013 (H7N9)
External Resource: Annotation
| Chains | Type | Family Name | Domain Identifier | Family Identifier | Provenance Source (Version) |
| A | SCOP2 Family | Sialidases (neuraminidases) | 8093677 | 4002683 | SCOP2 (2022-06-29) |
| A | SCOP2 Superfamily | Sialidases | 8093678 | 3001607 | SCOP2 (2022-06-29) |
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| A | | e6pzeA1 | A: Nat/Ivy | X: Acyl-CoA N-acyltransferases (Nat) | H: Acyl-CoA N-acyltransferases (Nat) | T: SBP_bac_1 | F: | ECOD (20:10:01) |
| C [auth H] | | e6pzeH1 | A: Nat/Ivy | X: Acyl-CoA N-acyltransferases (Nat) | H: Acyl-CoA N-acyltransferases (Nat) | T: SBP_bac_1 | F: | ECOD (20:10:01) |
| B [auth L] | | e6pzeL1 | A: Nat/Ivy | X: Acyl-CoA N-acyltransferases (Nat) | H: Acyl-CoA N-acyltransferases (Nat) | T: SBP_bac_1 | F: | ECOD (20:10:01) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| C [auth H] | Fab NA-45, anti-N9 | VH-CH1 | Homo sapiens (human) | IGHV4-39*01, IGHV4-39*07, IGHJ5*02, IGHG1*03, IGHG1*08, IGHG1*06 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_LAMBDA | IMGT (202609-0) |
| B [auth L] | Fab NA-45, anti-N9 | L-LAMBDA | Homo sapiens (human) | IGLV1-51*01, IGLJ1*01, IGLC2*01, IGLC2*02, IGLC3*04 | V-DOMAIN V-LAMBDA, C-DOMAIN C-LAMBDA | IG | FAB-GAMMA-1_LAMBDA | IMGT (202609-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| C [auth H] | Heavy Chain | IGHV4 | - | neuraminidase | SAbDab (2026-03-13) |
| B [auth L] | Light Chain | IGLV1 | Lambda | neuraminidase | SAbDab (2026-03-13) |
| Chains | Polymer | Molecular Function | Biological Process | Cellular Component |
|---|
| Neuraminidase | | | |
| C [auth H] | NA-45 FAB HEAVY CHAIN | - | - | - |
| B [auth L] | NA-45 FAB LIGHT CHAIN | - | - | - |